Italy Myasthenia Gravis Treatment Market Size & Outlook
Italy myasthenia gravis treatment market, 2018-2032 (US$M)
Related Markets
Italy myasthenia gravis treatment market highlights
- The Italy myasthenia gravis treatment market generated a revenue of USD 115.2 million in 2021 and is expected to reach USD 278.0 million by 2032.
- The Italy market is expected to grow at a CAGR of 8.3% from 2022 to 2032.
- In terms of segment, monoclonal antibodies was the largest revenue generating treatment type in 2021.
- Thymectomy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Myasthenia gravis treatment market data book summary
| Market revenue in 2021 | USD 115.2 million |
| Market revenue in 2032 | USD 278.0 million |
| Growth rate | 8.3% (CAGR from 2021 to 2032) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Thymectomy |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cholinesterase Inhibitors, Chronic Immunomodulators, Monoclonal Antibodies, Rapid Immunotherapies, Thymectomy |
| Key market players worldwide | AstraZeneca PLC, Grifols SA Ordinary Shares - Class A, Avadel Pharmaceuticals PLC, Novartis AG ADR, Pfizer Inc, AbbVie Inc, Roche Holding AG, GlaxoSmithKline, Bausch Health Companies Inc, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, Italy accounted for 6.6% of the global myasthenia gravis treatment market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2032.
- In Europe, UK myasthenia gravis treatment market is projected to lead the regional market in terms of revenue in 2032.
- UK is the fastest growing regional market in Europe and is projected to reach USD 280.7 million by 2032.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Myasthenia Gravis Treatment Market Scope
Myasthenia Gravis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy myasthenia gravis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to myasthenia gravis treatment market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 64.32% in 2021. Horizon Databook has segmented the Italy myasthenia gravis treatment market based on cholinesterase inhibitors, chronic immunomodulators, monoclonal antibodies, rapid immunotherapies, thymectomy covering the revenue growth of each sub-segment from 2018 to 2032.
Higher access to innovative diagnostic procedures and therapeutic approaches due to high healthcare expenditure and favorable reimbursement policies are supporting market growth. The healthcare system in the country is well-established, which is contributing to the growth of Italy myasthenia gravis treatment market.
The country provides universal healthcare coverage benefits to its citizens, but the Italian government is adopting special measures to ensure healthcare accessibility to the most vulnerable groups such as those suffering from MG. While private insurance alternatives are available, patients can avail public healthcare coverage regardless of their income.
The coverage is inclusive of all basic medical treatments for free or a small service charge with the only disadvantage of long waiting times. These steps help patients requiring regular or frequent visitations to manage their disease outcomes, thus boosting market growth.
Reasons to subscribe to Italy myasthenia gravis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy myasthenia gravis treatment market databook
-
Our clientele includes a mix of myasthenia gravis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy myasthenia gravis treatment market , including forecasts for subscribers. This country databook contains high-level insights into Italy myasthenia gravis treatment market from 2018 to 2032, including revenue numbers, major trends, and company profiles.
Partial client list
Italy myasthenia gravis treatment market size, by treatment type, 2018-2032 (US$M)
Italy Myasthenia Gravis Treatment Market Outlook Share, 2021 & 2032 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
